Peter Gray, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,358 shares at $152.32 ($359K) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Seasonal sale ($359k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.32 | 1,179 | $180K | 50.0% |
| 2 | $152.32 | 1,179 | $180K | 50.0% |
| Total | $152.32 avg | 2,358 | $359K | 100% |
| Filing → |
| JAZZ | SELL | 2021-08-10 | $418K | — | Filing → |
| JAZZ | SELL | 2019-08-12 | $214K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $253K | — | Filing → |